BioWorld Science

Aug. 28, 2013

View Archived Issues

Results presented for nanoliposomal irinotecan for the treatment of metastatic pancreatic cancer

Read More

The development of an optogenetic two-hybrid system for the control of mammalian gene transcription

Read More

Nuclear imaging of a novel radiolabeled probe for prostate cancer

Read More

Phase I study of GNX-5086 enrolls first healthy volunteer

Read More

Japanese researchers present new AMPA receptor modulators

Read More

Sareum Holdings patents novel agents for cancer

Read More

New cathepsin S and/or L inhibitors synthesized at Roche

Read More

Novel Der p 23 peptide-derived immunotherapy for house dust mite allergy

Read More

Researchers in China prepare new agents for HIV infection

Read More

Scientists in Germany disclose new agents for bacterial infections

Read More

Dainippon Sumitomo Pharma designs novel coagulation factor inhibitors

Read More

Subcutaneous Orencia launched in Japan for rheumatoid arthritis

Read More

Agenix and Arrayjet to jointly develop point-of-care diagnostic test

Read More

Spartan RX CYP2C19 assay receives FDA 510(k) clearance

Read More

Mount Sinai receives research grant for autism subtype study

Read More

BiondVax reports altered prime-boost strategy for its influenza vaccine

Read More

Orexigen receives DMC clearance to conduct interim analysis for the Light Study

Read More

OncoGenex reports Rainier trial initiation

Read More

Virttu Biologics treats first cohort in phase I/II mesothelioma study

Read More

Catalyst obtains FDA breakthrough therapy designation for Firdapse

Read More

Epilepsy treatment to be launched in Japan for partial-onset seizures

Read More

Health Canada approves Roche's Erivedge for advanced basal cell carcinoma

Read More

QRxPharma set to resubmit MoxDuo NDA

Read More

Medivir reports interim results from cohort 2 of COSMOS study

Read More

Bharat Biotech launches Typbar-TCV typhoid conjugate vaccine

Read More